A Photo‐Activated Thermoelectric Catalyst for Ferroptosis‐/Pyroptosis‐Boosted Tumor Nanotherapy
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202300699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Xiaoyan Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms, Photochemotherapy, Nanoparticles. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Phototherapy including photothermal therapy (PTT) and photodynamic therapy (PDT) has gradually come into the limelight for oncological treatment due to its noninvasiveness, high specificity, and low side effects. However, upregulated heat‐shock proteins (HSPs) and reactive oxygen species (ROS)‐defensing system such as glutathione (GSH) or MutT homolog 1 (MTH1) protein in tumor microenvironment counteract the efficiency of single‐modality therapy either PTT or PDT. Herein, the well‐defined bismuth telluride nanoplates (Bi 2 Te 3 NPs) are engineered with a high‐performance photo‐thermo‐electro‐catalytic effect for tumor‐synergistic treatment. Upon near‐infrared light illumination, Bi 2 Te 3 NPs induce a significant temperature elevation for PTT, which effectively inhibits MTH1 expression. Especially, heating and cooling alteration caused temperature variations result in electron–hole separation for ROS generation, which not only damages HSPs to reduce the thermotolerance for enhance PTT, but also arouses tumor cell pyroptosis. Additionally, Bi 2 Te 3 NPs conspicuously reduce GSH, further improving ROS level and leading to decrease glutathione peroxidase 4 (GPX4) activity, which triggers tumor cell ferroptosis. Due to the photo‐thermo‐electro‐catalytic synergistic therapy, Bi 2 Te 3 NPs are gifted with impressive tumor suppression on both ectopic and orthotopic ocular tumor models. This work highlights a high‐performance multifunctional energy‐conversion nanoplatform for reshaping tumor microenvironment to boost the tumor‐therapeutic efficacy of phototherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
- Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, P. R. China.
- Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200011, P. R. China.
ORCID-Profile: Yu Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, X., Yang, M., Fang, Y., Yang, Z., Dai, X., Gu, P., Feng, W., & Chen, Y. (2023). A Photo‐Activated Thermoelectric Catalyst for Ferroptosis‐/Pyroptosis‐Boosted Tumor Nanotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300699
Vancouver
Jiang X, Yang M, Fang Y, Yang Z, Dai X, Gu P, et al. A Photo‐Activated Thermoelectric Catalyst for Ferroptosis‐/Pyroptosis‐Boosted Tumor Nanotherapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300699
BibTeX
@article{Jiang2023,
author = {Jiang, Xiaoyan and Yang, Muyue and Fang, Ying and Yang, Zhenyu and Dai, Xinyue and Gu, Ping and Feng, Wei and Chen, Yu},
title = {A Photo‐Activated Thermoelectric Catalyst for Ferroptosis‐/Pyroptosis‐Boosted Tumor Nanotherapy},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202300699}
}
EUVIMED